Le réseautage au pouvoir synergique – Together for Synergistic Results


The Executive Team

From Left to Right: Mathieu Haddad, May Shawi, and Cliff Pavlovic (August 2012. Photo by Revan Caluya)


May Shawi 

President & CEO (Co-Founder)

May holds a PhD in Experimental Medicine from McGill University and currently works as a Medical Science Liaison. She has worked at Novartis in genetics and obtained a graduate degree in Biotechnology from Harvard University.

LinkedIn Profile: linkedin.com/in/mayshawi



Past Executives


Cliff Pavlovic    

Vice-President & Chief Operating Officer (Co-Founder & Chief Communications Officer)

The author of a comparative study between tech transfer in Québec and in Flanders, Cliff has also been involved in the knowledge and innovation economy: Lastly as an Intellectual Property Rights Officer at KU Leuven Research & Development, the technology transfer unit of KU Leuven University (Leuven, Belgium), and as a Technology Transfer Project Leader at Gestion Univalor, the technology transfer firm responsible for commercializing innovations from Université de Montréal and affiliated institutions.

LinkedIn Profile: linkedin.com/in/cliffpavlovic | Twitter: twitter.com/cliffpavlovic
Facebook: facebook.com/cliff.pavlovic | Google+: plus.google.com/+CliffPavlovic


Mathieu Haddad  

Chief Development Officer

Mathieu has a PhD in microbiology from Université de Montréal and is working on hydrogen bioaugmention of synthesis gas, issued from waste gasification. He has also worked at Suez Environnement (France) and at the Biotechnology Research Institute (NRC, Montreal) in the field of waste to energy. Mathieu has obtained his Master degree in biological engineering from the Université de Technologie de Compiègne (France).

LinkedIn Profile: linkedin.com/in/mathieuhaddad | Twitter: twitter.com/mathieu_haddad

Harry Karmouty 

Chief Operating Officer (Co-Founder)

Harry worked as a scientist at Novartis Pharma where he developed experimental models of respiratory disease, managed drug discovery programs and pioneered novel diagnostic techniques. He obtained a PhD in Pharmacology at King’s College London (UK).

LinkedIn Profile: linkedin.com/in/harrykarmouty